{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:33:59Z","timestamp":1777883639269,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"national institute on drug abuse","doi-asserted-by":"publisher","award":["K23 DA054157"],"award-info":[{"award-number":["K23 DA054157"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use: Research and Treatment"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>To mitigate COVID-19 exposure risks in methadone clinics, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a temporary modification of regulations in March 2020 to permit, with state concurrence, extended take-home methadone doses. The modification allowed for up to 28\u2009days of take-home methadone for stable patients and 14\u2009days for those less stable. Using both interrupted time series and difference-in-differences methods, this study examined the association between the policy change and fatal methadone overdoses, comparing states that permitted the expansion of take-home doses with states that did not. The findings suggest the pandemic emergency take-home policy did not increase methadone-involved mortality.<\/jats:p>","DOI":"10.1177\/29768357241272379","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T01:23:05Z","timestamp":1723857785000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Methadone Take-Home Policies and Associated Mortality: Permitting versus Non-Permitting States"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-0463","authenticated-orcid":false,"given":"Rebecca Arden","family":"Harris","sequence":"first","affiliation":[{"name":"Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"bibr1-29768357241272379","first-page":"25310","volume-title":"Medications for Opioid Use Disorder Save Lives","volume":"2019","author":"Committee on Medication-Assisted Treatment for Opioid Use Disorder, Board on Health Sciences Policy"},{"key":"bibr2-29768357241272379","unstructured":"Substance Abuse and Mental Health Services Administration. Methadone take-home flexibilities extension guidance. Accessed March 3, 2022. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/statutes-regulations-guidelines\/methadone-guidance"},{"key":"bibr3-29768357241272379","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, CDC WONDER Online Database. Data are from the multiple cause of death files as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. http:\/\/wonder.cdc.gov."},{"key":"bibr4-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1701700105"},{"key":"bibr5-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104302"},{"key":"bibr6-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2022.11.007"},{"key":"bibr7-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4308"},{"key":"bibr8-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz050"},{"key":"bibr9-29768357241272379","unstructured":"Facher L. Rigid rules at methadone clinics are jeopardizing patients\u2019 path to recovery from opioid addiction. STAT. Accessed March 12, 2024. https:\/\/www.statnews.com\/2024\/03\/12\/methadone-clinics-rigid-rules-opioid-addiction-recovery\/"},{"key":"bibr10-29768357241272379","unstructured":"U.S. Department of Health and Human Services. Medications for the treatment of opioid use disorder. Fed Regist. 2024;89. https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder"},{"key":"bibr11-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.1235"},{"key":"bibr12-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00564-9"},{"key":"bibr13-29768357241272379","unstructured":"National Institute on Drug Abuse. Medication to treat opioid use disorder. 2018. https:\/\/irp.nida.nih.gov\/wp-content\/uploads\/2019\/12\/NIDA-Medications-to-treat-opioid-use-disorder_2018.pdf"},{"key":"bibr14-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108276"},{"key":"bibr15-29768357241272379","unstructured":"U.S. Department of Justice. Drug Enforcement Administration, Diversion Control Division. Automated Reports and Consolidated Ordering System (ARCOS), Retail Drug Summary Reports, 2018, 2019, 2020, 2021, 2022. https:\/\/www.deadiversion.usdoj.gov\/arcos\/retail_drug_summary\/"},{"key":"bibr16-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2023.111579"},{"key":"bibr17-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1776"},{"key":"bibr18-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111283"},{"key":"bibr19-29768357241272379","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104487"}],"container-title":["Substance Use: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357241272379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29768357241272379","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357241272379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:52:57Z","timestamp":1777600377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29768357241272379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"alternative-id":["10.1177\/29768357241272379"],"URL":"https:\/\/doi.org\/10.1177\/29768357241272379","relation":{},"ISSN":["2976-8357","2976-8357"],"issn-type":[{"value":"2976-8357","type":"print"},{"value":"2976-8357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"article-number":"29768357241272379"}}